3 treatment centers
BHG Providence Treatment Center
Media, Pennsylvania
Mirmont Treatment Center
Media, Pennsylvania
Providence Treatment
Media, Pennsylvania
No centers match
Try a different search term
3 SAMHSA-listed treatment centers in Media, Pennsylvania. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Media, Pennsylvania
Media, Pennsylvania
Media, Pennsylvania
Try a different search term
Media, Pennsylvania has 3 SAMHSA-verified addiction treatment centers offering a range of evidence-based programs. Pennsylvania consistently ranks among the top states for overdose deaths, particularly in Philadelphia and Pittsburgh.
Available programs in Media include 1 residential/inpatient rehab program, 3 outpatient programs, 3 dual diagnosis (co-occurring mental health) programs, and 1 medical detox facility. All listed facilities are sourced directly from the federal SAMHSA National Registry of Substance Abuse Treatment Services.
Most treatment centers in Media accept Medicaid, Medicare, and major private insurance plans including Aetna, Cigna, BlueCross BlueShield, and UnitedHealthcare. Under the Affordable Care Act (ACA) and the Mental Health Parity Act, insurance providers are required to cover substance use disorder treatment at the same level as other medical conditions. Call (319) 271-2077 for a free insurance verification — no obligation, completely confidential.
When selecting from the 3 treatment options in Media, consider: the type and severity of the substance use disorder, whether co-occurring mental health conditions require dual diagnosis treatment, your insurance coverage and financial situation, the distance from home and your support network, and the facility's accreditation and evidence-based approach. Our helpline is available 24/7 at (319) 271-2077 to help match you with the right program — free and confidential.
Free, confidential assistance matching you with the right program in Media.
Treatment centers in Media accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
The decision to enter addiction treatment in Media, Pennsylvania, often follows a precipitating event — an overdose, a medical complication, a legal consequence, a family ultimatum, a job loss, or simply an internal recognition that the substance use has become unmanageable. Whatever the trigger, the next step is usually an admissions call. Admissions counselors in Media programs are trained to handle these conversations with people in active substance use, often experiencing shame and ambivalence, and to convert uncertain inquiries into safe transitions into clinical care.
Cost expectations for Media residential addiction treatment span a wide range: standard 30-day residential at facilities accepting most commercial insurance often runs $10,000-$30,000 in pre-insurance billing; premium or specialty programs (luxury, executive, specialized clinical focus) can run $30,000-$70,000+. With in-network commercial insurance, patient out-of-pocket typically lands at the plan's annual out-of-pocket maximum, often $7,000-$10,000 for an individual. Medicaid-covered treatment generally has no direct patient cost beyond modest copays where applicable.
ASAM levels of care available to Media residents range across the standard continuum: Level 1 outpatient counseling (less than 9 hours/week of structured programming), Level 2.1 intensive outpatient (9+ hours/week), Level 2.5 partial hospitalization (20+ hours/week), Level 3.1 clinically managed low-intensity residential, Level 3.5 medium-intensity residential, Level 3.7 medically monitored intensive inpatient, and Level 4 medically managed intensive inpatient (typically hospital-based detox for the most severe withdrawal presentations). Movement between levels follows clinical criteria, not calendar dates — patients step up when current intensity proves insufficient and step down as they stabilize.
Attention-deficit/hyperactivity disorder (ADHD) in Media treatment patients raises specific clinical questions: ADHD medication continuation (stimulant medications can be appropriate even in addiction-recovery contexts but require careful prescribing), evaluation of whether substance use was self-medication for untreated ADHD, and behavioral interventions for executive-function deficits that complicate early-recovery tasks like appointment-keeping, financial management, and structured-day adherence. Adult ADHD remains under-diagnosed in addiction-treatment populations.
Pregnant women in Media with active substance use should not stop opioid use abruptly if dependent — withdrawal during pregnancy carries fetal risk including preterm labor and stillbirth. Evidence-based care is buprenorphine or methadone maintenance (NOT detox), continued through pregnancy and postpartum. Pennsylvania maternal-fetal medicine specialists, OB-GYNs trained in addiction medicine, and SAMHSA's Center of Excellence for Pregnant and Postpartum Women with Opioid Use Disorder provide specialized care pathways for this population.
Sober living environments (SLEs) in Media and surrounding areas bridge residential treatment and full independent living. SLE quality varies considerably; the National Alliance for Recovery Residences (NARR) provides a certification framework with four quality levels (peer-run to clinically integrated). Reputable Media-area SLEs require drug testing, mutual-support meeting attendance, progressive responsibility (employment, household contribution), and structured-day adherence. Typical stay length is 3-12 months, longer for patients with severe addiction histories.
Family involvement in Media program admission typically begins with the admissions call itself — many patients seeking treatment have a family member or partner initiating the contact. Most facilities allow family conversations during the admission process (subject to 42 CFR Part 2 confidentiality), schedule family education or therapy sessions early in treatment, and explicitly involve family in discharge planning. Family-system engagement correlates with better treatment outcomes across the literature.